Literature DB >> 2417931

The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases.

K Krisch, I Krisch, G Horvat, N Neuhold, W Ulrich.   

Abstract

Thirty cases of medullary thyroid carcinoma were investigated by immunoperoxidase staining techniques to evaluate the diagnostic significance of neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), somatostatin (SOM), a-subunit of human chorionic gonadotrophin (a-hCG), serotonin (5-HT) and adrenocorticotropic hormone (ACTH) immunoreactivity as diagnostic markers in comparison to different calcitonin (CT) staining patterns. Twenty three cases exhibited a strong (group I) or moderate (group II) staining intensity for CT and did not need further immunocytochemical proof for classifying them as medullary carcinoma. From seven cases which showed only a weak or borderline CT-immunoreactivity (group III), six stained positively for NSE and four positively for CEA. SOM-positive cells were identified in six cases and a-hCG or 5-HT-positive cells respectively in three cases of group III. Twenty follicular and 20 papillary carcinomas also included in this study did not react with any of the above mentioned antibodies. Therefore, NSE and CEA represent useful additional diagnostic markers particularly for the identification of medullary carcinoma with weak or borderline CT-immunoreactivity. The identification of other peptides may also be helpful in demarcating it from thyroid tumours of follicular cell origin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2417931     DOI: 10.1111/j.1365-2559.1985.tb02786.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

Review 1.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

2.  Neuron-specific enolase in medullary thyroid carcinoma: immunohistochemical demonstration, but no significance as serum tumor marker.

Authors:  A Grauer; F Raue; E Rix; C Tschahargane; R Ziegler
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 3.  Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

Authors:  Ying-Hsia Chu; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

Review 4.  [Thyroid C cells and their pathology: Part 2: Medullary thyroid carcinoma].

Authors:  S Synoracki; S T Schmid; S Ting; K W Schmid
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

5.  The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases.

Authors:  Mauro Papotti; Daniela Sambataro; Carla Pecchioni; Gianni Bussolati
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

6.  Histopathological and immunohistochemical findings of primary and metastatic medullary thyroid carcinoma in a young dog.

Authors:  Pablo Piñeyro; Miranda D Vieson; José A Ramos-Vara; Martha Moon-Larson; Geoffrey Saunders
Journal:  J Vet Sci       Date:  2014-04-02       Impact factor: 1.672

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.